NCT00157534View on ClinicalTrials.gov

A Study to Evaluate the Safety and Efficacy of Celgosivir in Patients With Chronic Hepatitis C Genotype 1 Infection

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

October 31, 2004

Study Completion Date

August 31, 2005

Conditions
Hepatitis C, Chronic
Interventions
DRUG

Celgosivir

Sponsors
All Listed Sponsors
lead

BioWest Therapeutics Inc

INDUSTRY